Sponsor Pipeline

Grand Theravac Life Sciences (Nanjing) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
0
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
2
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07282249 Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in the Treatment… Chronic hepatitisB Not Yet Recruiting
Phase 2
NCT07179653 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to… HBV Infection Active, Not Recruiting
NCT07190742 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to… Chronic Hepatitis B Virus Active, Not Recruiting
Phase 1
NCT07673068 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of… HBV Infection Not Yet Recruiting
Early Phase 1
NCT07204236 Study to Evaluate Immunogenicity and Safety of TVAX-008 Injection in Non/Treated Chronic… Chronic Hepatitis B Active, Not Recruiting
Get alerts when Grand Theravac Life Sciences (Nanjing) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free